March 7, 2018 / 10:09 AM / 5 months ago

BRIEF-EMA Recommends Immediate Suspension, Recall Of Multiple Sclerosis Medicine Zinbryta

March 7 (Reuters) - EU Medicines Agency:

* EMA RECOMMENDS IMMEDIATE SUSPENSION AND RECALL OF MULTIPLE SCLEROSIS MEDICINE ZINBRYTA

* EMA RECOMMENDATION FOLLOWING 12 REPORTS OF SERIOUS INFLAMMATORY BRAIN DISORDERS WORLDWIDE, INCLUDING ENCEPHALITIS AND MENINGOENCEPHALITIS

* EMA’S RECOMMENDATION TO SUSPEND ZINBRYTA AND RECALL THE PRODUCT IS BEING SENT TO THE EUROPEAN COMMISSION FOR A LEGALLY BINDING DECISION

* PRELIMINARY REVIEW OF EVIDENCE INDICATES IMMUNE REACTIONS OBSERVED IN REPORTED CASES MAY BE LINKED TO USE OF ZINBRYTA‍​ Source text ID: (bit.ly/2oWAUEF) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below